Are you Dr. Benatar?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 53 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1150 Nw 14th St
Suite 609
Miami, FL 33136Phone+1 305-243-3100
Summary
- Dr. Michael Benatar, MD is a board certified neurologist in Miami, Florida. He is currently licensed to practice medicine in Florida and Georgia. He is affiliated with UMHC-Sylvester Comprehensive Cancer Center and University of Miami Hospital.
Education & Training
Beth Israel Deaconess Medical Center/Children's Hospital/Harvard Medical SchoolFellowship, Clinical Neurophysiology, 2002 - 2003- Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Neurology, 1999 - 2002
- Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 1998 - 1999
University of Cape Town Faculty of MedicineClass of 1992
Certifications & Licensure
FL State Medical License 2010 - 2025
GA State Medical License 2003 - 2011- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Clinical Research in ALS Study Start of enrollment: 2005 Feb 01
- The Pre-symptomatic Familial Amyotrophic Lateral Sclerosis (Pre-fALS) Study Start of enrollment: 2006 Apr 01
- Phase II/III Randomized, Placebo-controlled Trial of Arimoclomol in SOD1 Positive Familial Amyotrophic Lateral Sclerosis Start of enrollment: 2009 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Rethinking phase 2 trials in amyotrophic lateral sclerosis.Michael Benatar, Christopher McDermott, Martin R Turner, Ruben P A van Eijk
Brain. 2024-12-06 - Time to response with ravulizumab, a long-acting terminal complement inhibitor, in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gra...Ali A Habib, Michael Benatar, Tuan Vu, Andreas Meisel, Shahram Attarian
European Journal of Neurology. 2024-12-01 - Guidance for clinical management of pathogenic variant carriers at elevated genetic risk for ALS/FTD.Michael Benatar, Terry D Heiman-Patterson, Johnathan Cooper-Knock, Daniel Brickman, Kaitlin B Casaletto
Journal of Neurology, Neurosurgery, and Psychiatry. 2024-11-21
Press Mentions
Cartesian Therapeutics Expands Clinical Advisory Board with Five Internationally Recognized Experts in AutoimmunityMarch 28th, 2023- Miller School Makes History With NIH Research FundingMarch 8th, 2023
- Can Signs of MND Be Detected Before Symptoms Appear?January 6th, 2023
- Join now to see all
Professional Memberships
- Member
